StemCell Institute Inc. (TYO:7096)
Japan · Delayed Price · Currency is JPY 768.00
+3.00 (0.39%)
Jul 15, 2026, 3:30 PM JST
StemCell Institute Market Cap
StemCell Institute has a market cap or net worth of 7.87 billion as of July 15, 2026. Its market cap has decreased by -26.51% in one year.
Market Cap
7.87B
Enterprise Value
5.90B
Revenue
2.81B
Ranking
n/a
PE Ratio
50.04
Stock Price
768.00
Market Cap Chart
Since June 25, 2021, StemCell Institute's market cap has decreased from 21.16B to 7.87B, a decrease of -62.81%. That is a compound annual growth rate of -17.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 7.87B | -3.15% |
| Dec 30, 2025 | 8.13B | -38.48% |
| Dec 30, 2024 | 13.21B | -39.88% |
| Dec 29, 2023 | 21.97B | -17.47% |
| Dec 30, 2022 | 26.62B | 9.16% |
| Dec 30, 2021 | 24.39B | 15.25% |
| Jun 25, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immuno-Biological Laboratories | 9.31B |
| Nano Holdings | 8.82B |
| CellSeed | 8.81B |
| K Pharma,Inc. | 8.43B |
| OncoTherapy Science | 7.67B |
| Carna Biosciences | 7.46B |
| Kidswell Bio | 7.44B |
| ADR Biomedical Holdings | 7.21B |